b-arrestin 1 and 2 (also known as arrestin 2 and 3) are homologous adaptor proteins that regulate seven-transmembrane receptor trafficking and signalling. Other proteins with predicted 'arrestin-like' structural domains but lacking sequence homology have been indicated to function like b-arrestin in receptor regulation. We demonstrate that b-arrestin2 is the primary adaptor that rapidly binds agonist-activated b 2 adrenergic receptors (b 2 ARs) and promotes clathrin-dependent internalization, E3 ligase Nedd4 recruitment and ubiquitin-dependent lysosomal degradation of the receptor. The arrestin-domain-containing (ARRDC) proteins 2, 3 and 4 are secondary adaptors recruited to internalized b 2 AR-Nedd4 complexes on endosomes and do not affect the adaptor roles of b-arrestin2. Rather, the role of ARRDC proteins is to traffic Nedd4-b 2 AR complexes to a subpopulation of early endosomes.
INTRODUCTION
The two mammalian non-visual arrestins (b-arrestin 1 and 2, also known as arrestin 2 and 3) function as essential adaptors for the seven-transmembrane receptors (7TMRs; also known as G protein-coupled receptors or GPCRs) and regulate receptor desensitization, trafficking and signalling [1, 2] . The critical roles of b-arrestins are demonstrated by the perinatal lethality of b-arrestin1/b-arrestin2 double knockout mice and defects observed in single knockout mice for 7TMR-stimulated responses [3] . Mammalian cells also express arrestin-domaincontaining proteins (ARRDC 1-5 and the thioredoxin-interacting protein TXNIP), which have predicted structural similarities with arrestins but lack sequence homology [4] [5] [6] [7] .
All four arrestins (visual arrestin 1 and 4; non-visual arrestin 2 and 3) contain a characteristic a-helix in the N-terminal domain and a polar core that keeps the molecule constrained in a basal conformation, which is disrupted on arrestin-receptor interaction [8, 9] . Additionally, the b-arrestins have a welldefined clathrin-binding motif at the C-terminal domain [10] . Both b-arrestin1 and 2 bind HECT domain ligases and function as critical adaptors for ubiquitinating 7TMRs and ion channels/ transporters [11] [12] [13] [14] [15] .
TXNIP and ARRDC proteins 1-4 (but not ARRDC5) contain canonical PPXY motifs that bind WW domain-containing proteins, especially the HECT-domain-containing E3 ubiquitin ligases [4, 5] . Some ARRDCs are predicted to have an alpha helix in the N-terminal domain [5] . In yeast, a small family of arrestindomain-containing proteins with PPXY motifs function as arrestin-related trafficking adaptors for the yeast HECT domain E3 ligase Rsp5, which regulates ubiquitination and trafficking of plasma membrane amino-acid transporters [16] . Recently, ARRDC3 and not b-arrestin2 was reported to mediate Nedd4 recruitment to the b 2 adrenergic receptor (b 2 AR) to regulate receptor ubiquitination and degradation [17] . To explore what adaptors serve what functions in b 2 AR trafficking, we performed a series of biochemical and cellular assays to compare b-arrestin2 with ARRDC3.
RESULTS AND DISCUSSION b 2 AR endocytosis requires b-arrestin2, not ARRDC3
b-arrestins 1 and 2 mediate clathrin-dependent endocytosis of the b 2 AR [18] [19] [20] . Accordingly, exogenous expression of b-arrestin2, but not ARRDC3, led to an augmentation of Isoproterenol (Iso)-stimulated internalization of the b 2 AR in COS-7 cells (Fig 1A,B) . Additionally, in HEK-293 cells b 2 AR internalization was dramatically decreased by gene silencing of b-arrestin2 but not ARRDC3 (Fig 1C,D) . Concordant with previous findings on b-arrestinclathrin interaction [19, 21, 22] both b-arrestin1 and 2 interacted with endogenous clathrin and Iso-stimulation increased b-arrestin2-clathrin binding by B2-fold (Fig 1E) . In marked contrast, ARRDC3-clathrin binding was undetectable both basally and after Iso-stimulation (Fig 1E) . internalized receptors. HRS has been shown to regulate postendocytic sorting of 7TMRs and growth factor receptors [23, 24] . b-arrestins and ARRDC3 interacted with endogenous HRS, consistent with their roles in sorting internalized receptors into endosomes (Fig 1F,G) . Together with our internalization data, these data suggest that during b 2 AR trafficking, b-arrestin2 facilitates both early endocytic and post-endocytic steps, whereas ARRDC3 might facilitate just post-endocytic steps. b 2 AR ubiquitination/degradation requires b-arrestin2
Next, we compared b-arrestin2 and ARRDC3 for mediating agonist-stimulated Nedd4 recruitment to activated b 2 ARs. As previously described [12] , b-arrestin2 knockdown eliminated Iso-induced Nedd4-b 2 AR association (Fig 2A-C) . However, despite equivalent reduction of protein expression, ARRDC3 knockdown did not inhibit Iso-induced Nedd4-b 2 AR association (Fig 2A-C) . Concordantly, ARRDC3 knockdown did not affect Iso-stimulated (Fig 2D,E) , lysosomal trafficking (Fig 2F,G) or degradation as measured by radioligand binding (Fig 2H, supplementary Table S1 online). In marked contrast, b-arrestin2 knockdown resulted in a significant inhibition of Iso-stimulated ubiquitination ( Fig 2D,E) ; caused a substantial retention of b 2 ARs at the plasma membrane even after 6 h of Iso stimulation; significantly reduced colocalization of b 2 AR vesicles with the LysoTracker dye ( Fig 2F,G) ; and markedly inhibited receptor degradation after 24 h of Iso stimulation (Fig 2H, supplementary Table S1 online). These data confirm our earlier findings that b-arrestin2 acts as an essential adaptor for Nedd4 recruitment, receptor ubiquitination and lysosomal degradation [11, 12, 25] and demonstrate that ARRDC3 is not essential for promoting these effects.
Comparison of b-arrestin2, ARRDC3 and ARRDC3 AAXA Iso-stimulation increased the interaction between Nedd4 and b-arrestin2, as we reported before (Fig 3A,B) [12] . In contrast, although ARRDC3-Nedd4 binding was much more robust than b-arrestin-Nedd4 binding, there was little agonist-dependent increase (Fig 3A,B) . When the proline and tyrosine residues in the two PPXY motifs (supplementary Fig S1 online) were replaced with alanines, the resulting mutant ARRDC3 AAXA showed no Nedd4 binding because of the loss of WW domain interaction (Fig 3A,B) . In contrast, Nedd4 interaction with b-arrestin2 and another adaptor Grb10 does not involve WW domains [12, 26] . The rapid agonist-dependent recruitment of cytoplasmic b-arrestin2-GFP to the plasma membrane [18] is displayed in Fig 3C. In contrast, agonist stimulation did not markedly affect the subcellular distribution of ARRDC3-GFP in the cytoplasm and at the plasma membrane (Fig 3D) . Its cytoplasmic distribution is not homogeneous, but concentrated in vesicles, which have partial overlap with EEA1, an early endosome marker and LAMP2, a late endosomal/lysosomal marker (supplementary Fig S2 online) . The subcellular distribution of ARRDC3 AAXA differs from the WT: the mutant protein is localized at the plasma membrane but not concentrated in vesicles (Fig 3E) . Although WT ARRDC3 binds endogenous HRS, ARRDC3 AAXA is totally impaired (Fig 3F,G) . Additionally, although vesicles containing overexpressed WT-ARRDC3-GFP colocalized with HRS-positive endosomes, no endosomal localization is detected for ARRDC3 AAXA (Fig 3H) .
Internalized b 2 ARs colocalize with ARRDC3
Next we determined if b 2 AR and ARRDC3 can colocalize in HEK-293 cells and compared it with the known pattern of b-arrestin2-b 2 AR interaction. Before agonist stimulation, no colocalization is detected between the cytoplasmic b-arrestin2-GFP and the plasma-membrane-localized b 2 ARs (nonstimulated (NS) images, Fig 4A) . On agonist stimulation, a rapid and robust recruitment of b-arrestin2 to the activated b 2 ARs at the plasma membrane results (Fig 4A) . After 30 min of agonist activation, b-arrestin2 begins to redistribute to the cytoplasm and internalized b 2 ARs are seen in endosomes (Fig 4A) . This dissociation of internalized b 2 AR and b-arrestin2 is attributed to the deubiquitination of the latter by ubiquitin-specific protease 33 [27] .
In unstimulated cells, regions of plasma membrane showed some overlap of b 2 AR and ARRDC3-GFP (Fig 4B) . At 5 min after Iso-stimulation, few vesicles are detected with internalized b 2 AR and ARRDC3. However, after 30 and 60 min of Iso, most vesicles containing internalized b 2 ARs colocalized with ARRDC3-containing vesicles (Fig 4B) , but the membranedistributed ARRDC3 remained unchanged. This pattern suggests that rather than a co-trafficking event wherein ARRDC3 from the plasma membrane co-internalizes with the b 2 AR, actually, the internalized b 2 ARs are targeted to endosomes containing ARRDC3. ARRDC3 AAXA that is impaired in endosomal distribution but unimpaired in plasma membrane localization and incapable of interaction with Nedd4 and HRS (as shown in Fig 3) did not colocalize with the internalized b 2 AR (Fig 4C) . Additionally, ARRDC3 AAXA did not affect b 2 AR internalization (see distribution of b 2 AR mostly in endosomes in Iso-treated cells, Fig 4C, lower panels) . Collectively, these data do not support the notion that ARRDC3 recruits Nedd4 to the agonist-stimulated b 2 AR. Rather, they suggest the possibility that Nedd4, which is bound to the b 2 AR, might recruit the b 2 AR to ARRDC3 and HRS-containing endosomes.
Concordant with the confocal data, co-IP assays showed a marked increase in b-arrestin2-GFP-b 2 AR binding after 5 min of Iso stimulation, and a subsequent time-dependent decrease in the amount of b 2 AR-bound b-arrestin2 (Fig 4D) . In contrast, co-IP assays showed increased association of the b 2 AR with ARRDC3 only after 30 min of Iso treatment (Fig 4E,F) . Some basal binding of overexpressed ARRDC3 AAXA with the b 2 AR is detected in these chemically cross-linked samples. However, unlike the WT ARRDC3, there is no agonist-promoted increase in binding between the b 2 AR and ARRDC3 AAXA (Fig 4E,F) . The exact significance of the basal interaction between ARRDC3 and the b 2 AR at the plasma membrane remains to be determined; ARRDC3 could have a role in recycling of receptors or their targeting to membrane micro-domains. Nonetheless, these data suggest that Our data and conclusions differ from the recently reported effects of ARRDC3 on b 2 AR degradation [17] . These authors relied mostly on the characterization of a truncated b 2 AR, which would be impaired in normal GRK phosphorylation, b-arrestin recruitment and perhaps in ubiquitination in the C-terminal domain [25, 28] . They did observe a decrease in receptor binding with the polyproline mutant in immunoprecipitation assays, but concluded this to be a small decrease in receptor interaction; however, the expression levels of WT and mutant ARRDC3 were not carefully controlled in their experiments. These authors also used a single short interfering RNA (siRNA) oligo to knock down ARRDC3, which in our hands decreases both b-arrestin1 and 2 levels (supplementary Fig S3 online) .
To address the differences between our studies and that by Nabhan et al [17] , we further tested the specific siRNA used by the authors to knockdown ARRDC3 (oligo DC3-3). After Iso stimulation, both ubiquitination and internalization of the b 2 AR were impaired on knockdown with DC3-3 (supplementary Fig S4  online) . Moreover, only b-arrestin2 transfection rescued these defects, whereas a siRNA-resistant ARRDC3 'ARRDC3(W)' did not rescue either internalization or ubiquitination of the b 2 AR (supplementary Fig S4 online) . ARRDC3(W) showed identical subcellular distribution, as the WT ARRDC3 and colocalized with internalized b 2 ARs just as the WT ARRDC3 does (supplementary Fig S4 online) and its PPXY motifs are intact; therefore, its inability to rescue the siRNA effects was not because of any alteration in its expression or binding functions. Accordingly, the effects observed by Nabhan et al [17] on b 2 AR trafficking on siRNA knockdown were most probably because of a decrease in b-arrestin2 rather than a depletion of ARRDC3 levels.
ARRDC3 homologs also bind internalized b 2 ARs
Bioinformatics predictions [4, 5] suggest that ARRDC3 is closely related to ARRDC2 and ARRDC4 but only distantly related to ARRDC1, TXNIP and ARRDC5. As shown in Fig 4G, ARRDC1 -GFP is mainly localized at the plasma membrane and does not form a complex with internalized b 2 ARs on endosomes. TXNIP is mainly localized in the nucleus with little cytoplasmic distribution, and does not colocalize with internalized b 2 AR (supplementary Fig S5 online) . On the other hand, ARRDC2-GFP is expressed more on endosomes with some plasma membrane distribution, whereas ARRDC4-GFP showed identical subcellular distribution as ARRDC3-GFP (present both at the plasma membrane and in vesicles) and both proteins displayed a robust colocalization with internalized b 2 ARs on endosomes (Fig 4G) . Interestingly, when ARRDC3-cherry and either ARRDC2-GFP or ARRDC4-GFP were co-expressed, there was a significant overlap of subcellular distribution, especially on endosomes between these homologous proteins (supplementary Fig S6  online) . ARRDC2 and ARRDC4 also immunoprecipitated with the b 2 AR after 30 min of agonist stimulation (supplementary Fig S7  online) . ARRDC2 and ARRDC4 polyproline mutants were also impaired in endosomal distribution and did not colocalize with internalized b 2 AR similar to the ARRDC3 AAXA mutant (Fig 4H) . These data suggest that, like ARRDC3, ARRDC2 and ARRDC4 might regulate post-endocytic trafficking of the b 2 AR. Our attempts to knock down all three adaptors simultaneously were unsuccessful; future studies with new approaches would be required to delineate the redundant roles of ARRDCs. Indeed, the failure of ARRDC3 silencing to affect b 2 AR trafficking might be attributable to functional overlap among ARRDCs 2, 3 and 4.
b-arrestin and ARRDCs function sequentially
As shown in the schematic in Fig 4I, b-arrestin2 recruitment to activated b 2 ARs primarily initiates receptor endocytosis, Nedd4 recruitment and receptor ubiquitination. b-arrestin deubiquitination by USP33 causes dissociation of b-arrestin2 from the b 2 AR [27, 29] . Nedd4 bound to the b 2 AR connects the cargo to ARRDC containing endosomes promoting the sorting of Nedd4-b 2 AR complexes to HRS-positive endosomes. The ARRDC-Nedd4 interaction also regulates the binding of ARRDC and HRS on endosomes. Overall, b-arrestin2, Nedd4 and ARRDC function in a hierarchical manner to traffic the agoniststimulated b 2 AR to sorting endosomes; herein, the role of ARRDC is fulfilled by ARRDC 2, 3 or 4 all of which are equipotent in binding the cargo (b 2 AR), the regulatory ligase (Nedd4) and the endosomal-sorting molecule HRS.
The binding of internalized b 2 AR and ARRDC proteins on endosomes reveals an as yet unappreciated regulatory sorting mechanism for this 7TMR. Although the b 2 AR has been the most studied receptor since its cloning decades ago [30] , its intracellular itinerary is not fully understood. Several molecular mechanisms, including receptor phosphorylation/dephosphorylation, ubiquitination/deubiquitination, hydroxylation and so on, govern the residence time of the receptor at the cell surface and are in interplay in determining whether the agonist-stimulated receptor has to be deactivated and degraded or resensitized and recycled to the plasma membrane. Whether the interaction with ARRDC proteins is a 'by-stander' effect on cargo traffic through endosomes or a decision-rendering event during post-endocytic sorting demands further careful scrutiny.
METHODS
Immunoprecipitation assays. For all protein-protein interaction or ubiquitination assays, sub-confluent monolayers of cells were used. After agonist or vehicle treatments, cells were scraped into ice-cold lysis buffer supplemented with protease inhibitors as reported before [25] . Detection of Nedd4-b 2 AR complexes and b 2 AR-ARRDC3 interaction involved chemical cross-linking methods that have been described before [12] . Protein concentrations of clarified extracts were determined by a modified Bradford method. Roughly 600-800 mg of soluble protein solution was used for immunoprecipitation with anti-Flag affinity (Sigma) or antihaemagglutinin (HA) affinity agarose (Thermo Fisher) as required. The IP mixture was rotated at 4 1C and bound proteins were separated from unbound and non-specific interactions by repeated centrifugation and wash steps. Immunoprecipitated complexes were eluted by addition of SDS-polyacrylamide gel electrophoresis sample buffers and separated by 4-20% gradient gels or 10% gels (Invitrogen). Signals were detected and acquired with a CCD camera system (Bio-Rad Chemidoc-XRS) and analysed with Image-Lab software (Bio-Rad). Confocal microscopy. HEK-293 b 2 AR stable cells were transiently transfected with GFP-tagged b-arrestin or ARRDC constructs. 
